Cargando…
Gene-based anticoagulation regimens for an infant after mitral-valve replacement: A case report
RATIONALE: Heart-valve replacement is one of the main surgical methods for various heart-valve diseases. Warfarin is the only oral anticoagulant used for thrombosis prevention after heart-valve replacement. However, warfarin has a narrow therapeutic window, large differences in efficacy between indi...
Autores principales: | Cao, Hua, Xia, Xiaotong, Fu, Jinglan, Wu, Tingting, Chen, Wenjun, Dai, Ying, Xia, Xuan, Zhang, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959923/ https://www.ncbi.nlm.nih.gov/pubmed/31914049 http://dx.doi.org/10.1097/MD.0000000000018651 |
Ejemplares similares
-
Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial
por: Xia, Xiaotong, et al.
Publicado: (2019) -
Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020) -
Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin
por: Chen, Wenjun, et al.
Publicado: (2020) -
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients
por: Misasi, Silvia, et al.
Publicado: (2016) -
The value of ultrasound for detecting hand fractures: A meta-analysis
por: Zhao, Wenjun, et al.
Publicado: (2019)